This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Flash Therapeutics. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Jean-Christophe Pages
Introduction
Jean-Christophe Pages is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral systems for RNA transfer.
Latest Patents
Jean-Christophe Pages holds a patent for a "Retroviral particle comprising at least two encapsidated nonviral RNAs." This invention relates to a retroviral system designed for the transfer of non-viral RNA into target cells. The retroviral particle is capable of delivering multiple RNAs, comprising a protein derived from the Gag polyprotein, an envelope protein, and at least two encapsidated non-viral RNAs. Each encapsidated RNA sequence of interest is linked to an encapsidation sequence, which is recognized by a binding domain introduced into the Gag polyprotein or integrase.
Career Highlights
Jean-Christophe Pages has been instrumental in advancing the understanding of retroviral systems. His work has implications for gene therapy and the treatment of various diseases. He is associated with Flash Therapeutics, a company focused on innovative therapeutic solutions.
Collaborations
Jean-Christophe collaborates with Pascale Bouille, contributing to the advancement of their research and development efforts.
Conclusion
Jean-Christophe Pages is a prominent inventor whose work in retroviral systems showcases the potential for innovative solutions in biotechnology. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile